Bioavailability and metabolism of tea catechins in human subjects

Tea and Tea Products: Chemistry and Health-Promoting Properties

Volumn , Issue , 2008, Pages 111-129

  Sun, Ting ^a   Ho, Chi Tang ^b   Shahidi, Fereidoon ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954423898     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420008036-11     Document Type: Chapter

References (51)

1. Bode, A. M. and Dong, Z. 2003. Signal transduction pathways: Targets for green and black tea polyphenols. J. Biochem. Mol. Biol. 36:66-77.
2. Crespy, V. and Williamson, G. 2004. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr. 134:3431S-40S.
3. Wheeler, D. S. and Wheeler, W. J. 2004. The medicinal chemistry of tea. Drug Dev. Res. 61:45-65.
4. Yang, C. S., and Landau, J. M. 2000. Effects of tea consumption on nutrition and health. J. Nutr. 130:2409-12.
5. Zaveri, N. T. 2006. Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sci. 78:2073-80.
6. Cai, Y. and Chow, H. -H. S. 2004. Pharmacokinetics and bioavailability of green tea catechins. In Phytochemicals: Mechanisms of action, ed. M. S. Meskin, W. R. Bidlack, A. J. Davies, D. S. Lewis, and R. K. Randolph. Boca Raton, FL: CRC Press LLC, pp. 35-50.
7. Higdon, J. V. and Frei, B. 2003. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43:89-143.
8. Henning, S. M., Niu, Y., Lee, N. H., Thames, G. D., Minutti, R. R., Wang, H., Go, V. L. W., and Heber, D. 2004. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement Am. J. Clin. Nutr. 80:1558-64.
9. Wiseman, S., Mulder, T., and Rietveld, A. 2001. Tea flavonoids: Bioavailability in vivo and effects on cell signaling pathways in vitro. Antiox. Redox Signal 3:1009-21.
10. Holst, B. and Williamson, G. 2004. Methods to study bioavailability of phytochemicals. In Phytochemicals in health and disease, ed. R. Fenwick, 25-56. New York: Marcel Dekker.
11. Yang, C S., Landau, J M., Huang, M -T., and Newmark, H L 2001 Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21:381-406.
12. Warden, B. A., Smith, L. S., Beecher, G. R., Balentine, D. A., and Clevidence, B. A. 2001 Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 131:1731-37.
13. Vaidyanathan, J. B. and Walle, T. 2003. Cellular uptake and efflux of the tea flavonoid (−)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 307:745-52
14. Vaidyanathan, J. B. and Walle, T. 2001. Transport and metabolism of the tea flavonoid (−)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res. 18:1420-25.
15. Zhang, L., Chow, M. S. S., and Zuo, Z. 2006. Effect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea polyphenols in Caco-2 monolayer model. J. Pharm. Pharmacol. 58:37-44.
16. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P J. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:3-26.
17. Scalbert, A. and Williamson, G. 2000. Dietary intake and bioavailability of polyphenols J. Nutr. 130:2073S-85S
18. Yang, C., Chen, L., Lee, M., Balentine, D., Kuo, M., and Schantz, S. P 1998. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7:351-54.
19. Meng, X., Lee, M.-J., Li, C., Sang, S., Ho, C., and Yang, C. 2001. Formation and identification of 4′-0-methyl-(−)-epigallocatechin in humans. Drug Metab. Dispos.29:789-93
20. Zhang, L., Zheng, Y. C. M., and Zuo, Z. 2004. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm.287:1-12.
21. Meng, X., Sang, S., Zhu, N., Lu, H., Sheng, S., Lee, M., Ho, C., and Yang, C. 2002. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol. 15:1042-50.
22. Kuhnle, G., Spencer, J. P., Schroeter, H., Shenoy, B., Debnam, E. S., Srai, S. K., Rice-Evans, C., and Hahn, U. 2000. Epicatechin and catechin are o-methylated and gluc-uronidated in the small intestine. Biochem. Biophys. Res. Commun. 277:507-12.
23. Vaidyanathan, J. B. and Walle, T. 2002. Glucuronidation and sulfation of the tea flavonoid (−)-epicatechin by the human and rat enzymes. Drug Metab. Dispos. 30:897-903.
24. Li, C., Meng, X., Winnik, B., Lee, M. J., Lu, H., Sheng, S., Buckley, B., and Yang, C. S. 2001. Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem. Res. Toxicol. 14:702-7.
25. Li, C., Lee, M J., Sang, S M., Meng, X., Prabhu, S., Winnik, B., Huang, B., Chung, J Y., Yan, S., Ho, C. T., and Yang, C. S. 2000. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 13:177-84
26. van Amelsvoort, J. M., van Hof, K. H., Mathot, J. N., Mulder, T. P., Wiersma, A., and Tijburg, L. B. 2001. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica 31:891-901.
27. Zhu, B. T., Ezell, E. L., and Liehr, J. G. 1994. Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids-Metabolic inactivation as a possible reason for their lack of carcinogenicity in-vivo. J. Biol. Chem. 269:292-99.
28. Lee, M., Maliakal, P, Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G., Mohr, S., and Yang, C. S. 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 11:1025-32.
29. Chow, H H., Cai, Y., Alberts, D S., Hakim, I., Dorr, R., Shahi, F., Crowell, J A., Yang, C. S., and Hara, Y. 2001. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E Cancer Epidemiol. Biomarkers Prev. 10:53-58.
30. Ullmann, U., Haller, J., Decourt, J P., Girault, N., Girault, J., Richard-Caudron, A S., Pineau, B., and Weber, P 2003 A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 31:88-101.
31. Lee, M. J., Wang, Z. Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D. A., and Yang, C. S. 1995. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4:393-99.
32. Olthof, M. R., Hollman, P C. H., Buijsman, M. N. C. P., van Amelsvoort, J. M. M., and Katan, M. B. 2003. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 133:1806-14.
33. Mulder, T. P, Rietveld, A. G., and van Amelsvoort, J. M. 2005. Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine. Am. J. Clin. Nutr. 81:256S-60S
34. Daykin, C. A., van Duynhoven, J. P, Groenewegen, A., Dachtler, M., van Amelsvoort, J. M. M., and Mulder, T. P J. 2005. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. J. Agric. Food Chem.53:1428-34
35. Mulder, T. P J., van Platerink, C. J., Schuyl, P J. W., and van Amelsvoort, J. M. M. 2001 Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B 760:271-79.
36. Clifford, M. N., Copeland, E. L., Bloxsidgeoe, J. P., and Mitchell, L. A. 2000. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica30:317-26.
37. Gonthier, M. P, Cheynier, V., Donovan, J. L., Manach, C., Morand, C., Mila, I., Lapi-erre, C., Remesy, C., and Scalbert, A. 2003. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 133:461-67.
38. DuPont, M. S., Bennett, R. N., Mellon, F. A., and Williamson, G. 2002. Polyphenols from alcoholic apple cider are absorbed, metabolized and excreted by humans. J. Nutr.132:172-75.
39. Rechner, A. R., Spencer, J. P E., Kuhnle, G., Hahn, U., and Rice-Evans, C. A. 2001. Novel biomarkers of the metabolism of caffeic acid derivatives in vivo Free Radic. Biol. Med. 30:1213-22.
40. Henning, S. A., Aronson, W., Liu, Y., Conde, F., Lee, N. H., Seeram, N. P., Lee, R. -P., Lu, J., Harris, D. M., Moro, A., Hong, J., Pak-Shan, L., Barnard, R. J., Ziaee, H. G., Csathy, G., Go, V. L. W., Wang, H., and Herber, D. 2006. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J. Nutr. 136:1839-43.
41. Manach, C., Scalbert, A., Morand, C., Remesy, C., and Jimenez, L. 2004. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 79:727-47.
42. Manach, C., Williamson, G., Morand, C., Scalbert, A., and Remesy, C 2005 Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 81:230S-42S
43. Natsume, M., Osakabe, N., Oyama, M., Sasaki, M., Baba, S., Nakamura, Y., Osawa, T., and Terao, J. 2003. Structures of (−)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (−)-epicatechin: Differences between human and rat. Free Radic. Biol. Res. 34:840-49.
44. Chen, L., Lee, M.-J., Li, H., and Yang, C. S. 1997. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab. Dispos. 25:1045-50.
45. Chow, H. H. S., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y., and Alberts, D. S. 2003. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and Polyphenon E in healthy individuals. Clin. Cancer. Res. 9:3312-19.
46. Langley-Evans, S C 2000 Consumption of black tea elicits an increase in plasma antioxidant potential in humans. Int. J. Food Sci. Nutr. 51:309-15.
47. Rietveld, A and Wiseman, S 2003 Antioxidant effects of tea: Evidence from human clinical trials. J. Nutr. 133:3285S-92S.
48. Piettaa, P G., Simonettib, P., Gardanab, C., Brusamolinob, A., Morazzonic, P., and Bombardellic, E. 1998. Catechin metabolites after intake of green tea infusions. Biofactors 8:111-18.
49. Yoshino, K., Suzuki, M., Sasaki, K., Miyase, T., and Sano, M. 1999. Formation of antioxidants from (−)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma. J. Nutr. Biochem. 10:223-29.
50. Pisters, K. M. W., Newman, R. A., Coldman, B., Shin, D. M., Khuri, F. R., Hong, W. K., Glisson, B. S., and Lee, J. S. 2001. Phase I trial of oral green tea extract in adult patients with solid tumors. J. Clin. Oncol. 19:1830-38.
51. Chow, H -H S., Hakim, I A., Vining, D R., Crowell, J A., Ranger-Moore, J., Chew, W M., Celaya, C. A., Rodney, S. R., Hara, Y., and Alberts, D. S. 2005. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res. 11:4627-33.